Buprenorphine Transdermal and Daclatasvir Dihydrochloride
Determining the interaction of Buprenorphine Transdermal and Daclatasvir Dihydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Transdermal-Daclizumab
- Buprenorphine Transdermal-Daclizumab Subcutaneous
- Buprenorphine Transdermal-Dacogen
- Buprenorphine Transdermal-Dacomitinib
- Buprenorphine Transdermal-Dactinomycin
- Buprenorphine Transdermal-Dactinomycin Injection
- Daclatasvir Dihydrochloride-Buprenorphine Transdermal Patch
- Daclatasvir Dihydrochloride-Buprenorphine transdermal skin patch
- Daclatasvir Dihydrochloride-Buprenorphine, Buprenorphine Hydrochloride
- Daclatasvir Dihydrochloride-Buprenorphine/naloxone Oromucosal, Sublingual
- Daclatasvir Dihydrochloride-Buproban
- Daclatasvir Dihydrochloride-Bupropion